Chelsea Therapeutics (CHTP) Price Target Raised to $8 at Deutsche Bank
Tweet Send to a Friend
Deutsche Bank maintained a Hold rating on Chelsea Therapeutics (NASDAQ: CHTP) and raised its price target to $8.00 (from $5) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
